vs

Side-by-side financial comparison of INTEST CORP (INTT) and Medirom Healthcare Technologies Inc. (MRM). Click either name above to swap in a different company.

INTEST CORP is the larger business by last-quarter revenue ($32.8M vs $21.1M, roughly 1.6× Medirom Healthcare Technologies Inc.). INTEST CORP runs the higher net margin — 3.8% vs -21.3%, a 25.1% gap on every dollar of revenue. Medirom Healthcare Technologies Inc. produced more free cash flow last quarter ($-2.4K vs $-1.6M).

INTTEST Corp designs, manufactures and distributes precision test and process control solutions for the global semiconductor manufacturing ecosystem. Its offerings include thermal management systems, test interface hardware, and wafer handling tools, serving semiconductor fabs, chip design firms, and automotive and industrial electronics end segments.

Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.

INTT vs MRM — Head-to-Head

Bigger by revenue
INTT
INTT
1.6× larger
INTT
$32.8M
$21.1M
MRM
Higher net margin
INTT
INTT
25.1% more per $
INTT
3.8%
-21.3%
MRM
More free cash flow
MRM
MRM
$1.6M more FCF
MRM
$-2.4K
$-1.6M
INTT

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
INTT
INTT
MRM
MRM
Revenue
$32.8M
$21.1M
Net Profit
$1.2M
$-4.5M
Gross Margin
45.4%
10.8%
Operating Margin
3.9%
-28.5%
Net Margin
3.8%
-21.3%
Revenue YoY
-10.3%
Net Profit YoY
-17.4%
EPS (diluted)
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INTT
INTT
MRM
MRM
Q4 25
$32.8M
Q3 25
$26.2M
Q2 25
$28.1M
$21.1M
Q1 25
$26.6M
Q4 24
$36.6M
Q3 24
$30.3M
Q2 24
$34.0M
Q1 24
$29.8M
Net Profit
INTT
INTT
MRM
MRM
Q4 25
$1.2M
Q3 25
$-938.0K
Q2 25
$-503.0K
$-4.5M
Q1 25
$-2.3M
Q4 24
$1.5M
Q3 24
$495.0K
Q2 24
$230.0K
Q1 24
$662.0K
Gross Margin
INTT
INTT
MRM
MRM
Q4 25
45.4%
Q3 25
41.9%
Q2 25
42.6%
10.8%
Q1 25
41.5%
Q4 24
39.7%
Q3 24
46.3%
Q2 24
40.6%
Q1 24
43.8%
Operating Margin
INTT
INTT
MRM
MRM
Q4 25
3.9%
Q3 25
-4.5%
Q2 25
-3.3%
-28.5%
Q1 25
-10.8%
Q4 24
5.7%
Q3 24
1.6%
Q2 24
1.0%
Q1 24
1.6%
Net Margin
INTT
INTT
MRM
MRM
Q4 25
3.8%
Q3 25
-3.6%
Q2 25
-1.8%
-21.3%
Q1 25
-8.7%
Q4 24
4.1%
Q3 24
1.6%
Q2 24
0.7%
Q1 24
2.2%
EPS (diluted)
INTT
INTT
MRM
MRM
Q4 25
$0.10
Q3 25
$-0.08
Q2 25
$-0.04
Q1 25
$-0.19
Q4 24
$0.13
Q3 24
$0.04
Q2 24
$0.02
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INTT
INTT
MRM
MRM
Cash + ST InvestmentsLiquidity on hand
$14.2M
$252.3K
Total DebtLower is stronger
$8.8M
Stockholders' EquityBook value
$103.6M
$1.6M
Total Assets
$151.3M
$52.0M
Debt / EquityLower = less leverage
5.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INTT
INTT
MRM
MRM
Q4 25
$14.2M
Q3 25
$16.2M
Q2 25
$19.2M
$252.3K
Q1 25
$22.0M
Q4 24
$19.8M
Q3 24
$18.0M
Q2 24
$20.4M
Q1 24
$27.3M
Total Debt
INTT
INTT
MRM
MRM
Q4 25
Q3 25
$4.9M
Q2 25
$5.9M
$8.8M
Q1 25
$6.9M
Q4 24
$7.9M
Q3 24
$9.0M
Q2 24
$10.0M
Q1 24
$11.0M
Stockholders' Equity
INTT
INTT
MRM
MRM
Q4 25
$103.6M
Q3 25
$101.9M
Q2 25
$102.6M
$1.6M
Q1 25
$99.4M
Q4 24
$99.8M
Q3 24
$100.4M
Q2 24
$99.5M
Q1 24
$99.3M
Total Assets
INTT
INTT
MRM
MRM
Q4 25
$151.3M
Q3 25
$148.3M
Q2 25
$149.7M
$52.0M
Q1 25
$148.0M
Q4 24
$152.3M
Q3 24
$158.4M
Q2 24
$160.6M
Q1 24
$159.5M
Debt / Equity
INTT
INTT
MRM
MRM
Q4 25
Q3 25
0.05×
Q2 25
0.06×
5.55×
Q1 25
0.07×
Q4 24
0.08×
Q3 24
0.09×
Q2 24
0.10×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INTT
INTT
MRM
MRM
Operating Cash FlowLast quarter
$-1.0M
$-2.3K
Free Cash FlowOCF − Capex
$-1.6M
$-2.4K
FCF MarginFCF / Revenue
-4.7%
-0.0%
Capex IntensityCapex / Revenue
1.6%
0.0%
Cash ConversionOCF / Net Profit
-0.82×
TTM Free Cash FlowTrailing 4 quarters
$5.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INTT
INTT
MRM
MRM
Q4 25
$-1.0M
Q3 25
$3.5M
Q2 25
$-688.0K
$-2.3K
Q1 25
$5.5M
Q4 24
$2.6M
Q3 24
$4.2M
Q2 24
$-5.1M
Q1 24
$2.1M
Free Cash Flow
INTT
INTT
MRM
MRM
Q4 25
$-1.6M
Q3 25
$3.1M
Q2 25
$-1.1M
$-2.4K
Q1 25
$5.3M
Q4 24
$2.4M
Q3 24
$3.7M
Q2 24
$-5.4M
Q1 24
$1.7M
FCF Margin
INTT
INTT
MRM
MRM
Q4 25
-4.7%
Q3 25
11.8%
Q2 25
-4.1%
-0.0%
Q1 25
19.9%
Q4 24
6.6%
Q3 24
12.4%
Q2 24
-15.9%
Q1 24
5.8%
Capex Intensity
INTT
INTT
MRM
MRM
Q4 25
1.6%
Q3 25
1.6%
Q2 25
1.6%
0.0%
Q1 25
0.9%
Q4 24
0.4%
Q3 24
1.7%
Q2 24
0.9%
Q1 24
1.1%
Cash Conversion
INTT
INTT
MRM
MRM
Q4 25
-0.82×
Q3 25
Q2 25
Q1 25
Q4 24
1.72×
Q3 24
8.58×
Q2 24
-22.13×
Q1 24
3.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INTT
INTT

Environmental Technologies$8.3M25%
Semiconductor Market$6.9M21%
Thermal Testing Products$6.4M19%
Service And Other Products$4.8M15%
Oem Integrators And Distributor$3.5M11%
Semiconductor Production Test Products$3.0M9%

MRM
MRM

Professional services expense$20.0M95%
Other$1.1M5%

Related Comparisons